España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Protara Therapeutics
TARA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.69
0.11
4.26%
At close: -
$2.80
0.11
4.09%
After Hours: 6:48 PM EDT
Get Report
Comment
Q3 2024 Earnings were released on Tue Nov 12th, before the market open
Protara Therapeutics (TARA) Forecast
News
Earnings
Protara Therapeutics (TARA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Protara Therapeutics (NASDAQ:TARA) Stock
Protara Therapeutics Stock (NASDAQ: TARA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 12, 2024
Protara Therapeutics Q3 EPS $(0.50) Beats $(0...
Benzinga Newsdesk
Monday, October 21, 2024
Protara's IV Choline Chloride Receives FDA Fa...
Benzinga Newsdesk
Monday, September 09, 2024
Protara Therapeutics Announces Results From T...
Benzinga Newsdesk
Protara Therapeutics Completes First Cohort O...
Benzinga Newsdesk
Monday, August 12, 2024
Oppenheimer Maintains Outperform on Protara T...
Benzinga Newsdesk
Thursday, August 08, 2024
HC Wainwright & Co. Reiterates Buy on Protara...
Benzinga Newsdesk
Tuesday, August 06, 2024
Protara Therapeutics Q2 EPS $(0.45) Beats $(0...
Benzinga Newsdesk
Thursday, May 09, 2024
Watching Protara Therapeutics, Opthea Ltd.; S...
Benzinga Newsdesk
Monday, May 06, 2024
HC Wainwright & Co. Reiterates Buy on Protara...
Benzinga Newsdesk
Thursday, May 02, 2024
Protara Therapeutics Q1 EPS $(0.97) Misses $(...
Benzinga Newsdesk
Monday, April 22, 2024
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Oppenheimer Maintains Outperform on Protara T...
Benzinga Newsdesk
Monday, April 08, 2024
HC Wainwright & Co. Maintains Buy on Protara ...
Benzinga Newsdesk
Friday, April 05, 2024
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
Vandana Singh
Protara Therapeutics shares are trading highe...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Protara Therapeutics Announces Oversubscribed...
Benzinga Newsdesk
Protara Therapeutics Announces Alignment With...
Benzinga Newsdesk
Thursday, March 14, 2024
HC Wainwright & Co. Reiterates Buy on Protara...
Benzinga Newsdesk
Wednesday, March 13, 2024
Protara Therapeutics Q4 EPS $(0.90) Beats $(0.92) Estimate
Happy Mohamed
Monday, March 04, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Monday, December 11, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, November 30, 2023
Protara Therapeutics Announces Presentation O...
Benzinga Newsdesk
Friday, November 03, 2023
Protara Therapeutics Q3 EPS $(0.87) Beats $(0...
Benzinga Newsdesk
Monday, October 23, 2023
Protara Therapeutics Announces Dosing Of Firs...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Wednesday, September 20, 2023
Protara Therapeutics Announces Dosing of Firs...
Benzinga Newsdesk
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, September 11, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, September 06, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, August 04, 2023
HC Wainwright & Co. Reiterates Buy on Protara...
Benzinga Newsdesk
Thursday, August 03, 2023
Protara Therapeutics Q2 EPS $(1.00) Misses $(0.87) Estimate
Happy Mohamed
Monday, July 10, 2023
Guggenheim Assumes Protara Therapeutics at Bu...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Monday, May 15, 2023
Protara Therapeutics Announces Dosing Of Firs...
Benzinga Newsdesk
Monday, May 08, 2023
HC Wainwright & Co. Reiterates Buy on Protara...
Benzinga Newsdesk
Thursday, May 04, 2023
Recap: Protara Therapeutics Q1 Earnings
Benzinga Insights
Protara Therapeutics Q1 EPS $(0.80) Up From $(0.96) YoY
Happy Mohamed
Tuesday, May 02, 2023
Protara Therapeutics Receives Regulatory Clea...
Benzinga Newsdesk
Monday, May 01, 2023
HC Wainwright & Co. Reiterates Buy on Protara...
Benzinga Newsdesk
Friday, April 28, 2023
Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer
Vandana Singh
Protara Therapeutics Announces Preliminary Data From ADVANCED-1 Phase 1a Dose Escalation Trial Of TARA-002 in NMIBC Supporting Advancement Into Phase 2 Clinical Development
Happy Mohamed
Thursday, March 09, 2023
HC Wainwright & Co. Reiterates Buy on Protara...
Benzinga Newsdesk
Wednesday, March 08, 2023
UPDATE: ArTara Therapeutics Q4 Adj. EPS $(0.84) Misses $(0.75) Estimate
Happy Mohamed
ArTara Therapeutics Q4 Adj. EPS $(0.84) Misse...
Benzinga Newsdesk
Monday, January 30, 2023
Protara Therapeutics Appoints Patrick Fabbio ...
Benzinga Newsdesk
Wednesday, November 09, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, November 08, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
